e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Lunchtime programme: meet the Awardees and the Young Investigators of the Occupation and Epidemiology Assembly
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Awarding of the Occupation and Epidemiology Best Papers
J. Grigg (London, United Kingdom), M. Bednarek (Warsaw, Poland)
Source:
Annual Congress 2007 - Lunchtime programme: meet the Awardees and the Young Investigators of the Occupation and Epidemiology Assembly
Session:
Lunchtime programme: meet the Awardees and the Young Investigators of the Occupation and Epidemiology Assembly
Session type:
Symposium
Number:
3966
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Grigg (London, United Kingdom), M. Bednarek (Warsaw, Poland). Awarding of the Occupation and Epidemiology Best Papers. Annual Congress 2007 - Lunchtime programme: meet the Awardees and the Young Investigators of the Occupation and Epidemiology Assembly
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Success of smoking cessation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
Evidence for the onset of COPD in childhood, and the role of genetics
Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence
Year: 2005
Lung function decline, chronic bronchitis and occupational exposures during the follow-up of the ECRHS
Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Year: 2005
Why is there often discordance between cross sectional and longitudinal studies of dust-induced COPD?
Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Year: 2005
FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007
Population surveillance in North West Adelaide: lung function and chronic obstructive pulmonary disease (COPD) across the diabetes spectrum
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV
1
) in patients with severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008
The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics
Source: Eur Respir J 2003; 21: 95-10
Year: 2003
Effect of tiotropium on spontaneous expiratory flow-volume curves during exercise in GOLD 1&2 COPD
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013
The interaction between family history of COPD, personal smoking and post-bronchodilator airflow obstruction: A cohort study
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Annual FEV1 change : Post tuberculosis obstructive airway disease versus COPD
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6
Source: Eur Respir J 2006; 27: 378-383
Year: 2006
Does rapid decline predict poor prognosis?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007
Efficacy of confronting smokers with airflow limitation for smoking cessation
Source: Eur Respir J 2009; 33: 754-762
Year: 2009
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002
Detection of spirometrically-defined COPD in a population of smokers referred to a smoking cessation clinic
Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation
Year: 2006
Introductory lecture: Nicotine addiction treatment in COPD patients
Source: Annual Congress 2007 - Smoking and COPD
Year: 2007
Developing COPD – a 25 year follow-up study of the general population
Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Year: 2005
Quality of life in patients with chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=375
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept